| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.782 | 0.004 | 0.782 | Hypolipemic | 0.731 0.004 DBMET02115 0.656 0.005 DBMET02116 0.673 0.005 DBMET02118 0.623 0.005 DBMET02117 | ||
| 0.728 | 0.006 | 0.863 | Cholesterol antagonist | 0.863 0.003 DBMET02115 0.612 0.017 DBMET02116 0.812 0.004 DBMET02118 0.77 0.005 DBMET02117 | DBMET02115 | |
| 0.48 | 0.036 | 0.48 | Calcium channel L-type activator | 0.305 0.153 DBMET02115 0.288 0.168 DBMET02118 | ||
| 0.472 | 0.049 | 0.702 | Antibacterial | 0.702 0.009 DBMET02115 0.376 0.088 DBMET02116 0.667 0.011 DBMET02118 0.676 0.011 DBMET02117 | DBMET02115 | |
| 0.399 | 0.066 | 0.429 | Antiobesity | 0.429 0.055 DBMET02115 0.224 0.182 DBMET02116 0.381 0.073 DBMET02118 0.31 0.109 DBMET02117 | DBMET02115 | |
| 0.3 | 0.006 | 0.3 | Farnesoid X receptor antagonist | 0.193 0.024 DBMET02115 0.261 0.01 DBMET02116 0.185 0.027 DBMET02118 0.159 0.043 DBMET02117 | ||
| 0.366 | 0.111 | 0.712 | Cyclophilin D inhibitor | 0.712 0.013 DBMET02115 0.263 0.198 DBMET02116 0.646 0.02 DBMET02118 0.694 0.015 DBMET02117 | DBMET02115 | |
| 0.229 | 0.005 | 0.295 | Purinergic P2 antagonist | 0.085 0.029 DBMET02115 0.295 0.005 DBMET02116 0.076 0.035 DBMET02118 0.112 0.018 DBMET02117 | DBMET02116 | |
| 0.297 | 0.076 | 0.44 | Interleukin 2 agonist | 0.405 0.026 DBMET02115 0.226 0.148 DBMET02116 0.44 0.018 DBMET02118 0.382 0.033 DBMET02117 | DBMET02118 | |
| 0.253 | 0.049 | 0.37 | Peptidyltransferase inhibitor | 0.37 0.009 DBMET02115 0.344 0.013 DBMET02118 0.329 0.016 DBMET02117 | DBMET02115 | |
| 0.264 | 0.069 | 0.38 | Interleukin agonist | 0.38 0.022 DBMET02115 0.376 0.023 DBMET02118 0.279 0.06 DBMET02117 | DBMET02115 | |
| 0.201 | 0.005 | 0.201 | Interleukin 5 antagonist | 0.165 0.008 DBMET02115 0.11 0.031 DBMET02118 | ||
| 0.284 | 0.101 | 0.44 | Vasodilator, coronary | 0.44 0.025 DBMET02115 0.212 0.171 DBMET02116 0.435 0.026 DBMET02118 0.386 0.04 DBMET02117 | DBMET02115 | |
| 0.182 | 0.003 | 0.204 | Purinergic P2X3 antagonist | 0.09 0.005 DBMET02115 0.204 0.003 DBMET02116 0.088 0.005 DBMET02118 0.103 0.004 DBMET02117 | DBMET02116 | |
| 0.224 | 0.055 | 0.224 | Nitric-oxide synthase stimulant | 0.216 0.065 DBMET02115 0.204 0.083 DBMET02116 0.176 0.139 DBMET02118 0.2 0.089 DBMET02117 | ||
| 0.165 | 0.005 | 0.205 | Purinergic P2X antagonist | 0.049 0.034 DBMET02115 0.205 0.004 DBMET02116 0.044 0.04 DBMET02118 0.059 0.024 DBMET02117 | DBMET02116 | |
| 0.249 | 0.089 | 0.281 | 5 Hydroxytryptamine release stimulant | 0.281 0.076 DBMET02116 0.165 0.159 DBMET02118 0.173 0.149 DBMET02117 | DBMET02116 | |
| 0.179 | 0.022 | 0.179 | Bronchodilator | |||
| 0.185 | 0.037 | 0.354 | Cell wall synthesis inhibitor | 0.354 0.008 DBMET02115 0.119 0.101 DBMET02116 0.277 0.012 DBMET02118 0.277 0.012 DBMET02117 | DBMET02115 | |
| 0.237 | 0.097 | 0.306 | Spasmolytic | 0.306 0.068 DBMET02115 0.169 0.146 DBMET02118 0.215 0.108 DBMET02117 | DBMET02115 | |
| 0.223 | 0.112 | 0.325 | 5 Hydroxytryptamine uptake stimulant | 0.325 0.034 DBMET02116 | DBMET02116 | |
| 0.241 | 0.138 | 0.244 | Sodium/bile acid cotransporter inhibitor | 0.244 0.134 DBMET02116 0.198 0.191 DBMET02117 | DBMET02116 | |
| 0.11 | 0.015 | 0.124 | DNA gyrase inhibitor | 0.124 0.012 DBMET02115 | DBMET02115 | |
| 0.218 | 0.123 | 0.281 | Lipoxygenase inhibitor | 0.281 0.081 DBMET02116 | DBMET02116 | |
| 0.131 | 0.037 | 0.142 | Estrogen antagonist | 0.142 0.027 DBMET02116 0.102 0.093 DBMET02118 | DBMET02116 | |
| 0.097 | 0.005 | 0.097 | Antiviral (Hepatitis D) | 0.061 0.021 DBMET02115 0.077 0.01 DBMET02116 0.053 0.031 DBMET02118 | ||
| 0.159 | 0.067 | 0.159 | Acetylcholine M1 receptor antagonist | |||
| 0.118 | 0.034 | 0.121 | Estrogen receptor beta antagonist | 0.121 0.031 DBMET02116 | DBMET02116 | |
| 0.276 | 0.194 | 0.371 | 5 Hydroxytryptamine release inhibitor | 0.317 0.146 DBMET02115 0.311 0.153 DBMET02116 0.371 0.098 DBMET02117 | DBMET02117 | |
| 0.103 | 0.025 | 0.109 | Estrogen receptor alpha antagonist | 0.109 0.022 DBMET02116 | DBMET02116 | |
| 0.166 | 0.094 | 0.263 | P-glycoprotein inhibitor | 0.17 0.089 DBMET02115 0.263 0.038 DBMET02116 0.145 0.125 DBMET02118 0.242 0.044 DBMET02117 | DBMET02116 | |
| 0.108 | 0.039 | 0.152 | Phosphodiesterase 6D inhibitor | 0.152 0.009 DBMET02115 0.132 0.017 DBMET02118 0.111 0.034 DBMET02117 | DBMET02115 | |
| 0.072 | 0.004 | 0.072 | Prostaglandin D2 agonist | 0.055 0.006 DBMET02115 0.031 0.021 DBMET02116 0.041 0.012 DBMET02118 | ||
| 0.167 | 0.105 | 0.167 | Interleukin antagonist | |||
| 0.106 | 0.044 | 0.106 | NMDA receptor antagonist | |||
| 0.066 | 0.008 | 0.066 | Prostaglandin agonist | |||
| 0.128 | 0.074 | 0.128 | Interleukin 4 antagonist | 0.126 0.077 DBMET02115 0.111 0.1 DBMET02118 | ||
| 0.091 | 0.037 | 0.091 | NMDA 2 receptor antagonist | |||
| 0.118 | 0.069 | 0.118 | Acetylcholine muscarinic antagonist | |||
| 0.091 | 0.044 | 0.091 | Adrenaline agonist | |||
| 0.073 | 0.028 | 0.073 | Androgen agonist | 0.055 0.048 DBMET02116 | ||
| 0.155 | 0.112 | 0.172 | Psychostimulant | 0.15 0.116 DBMET02115 0.143 0.122 DBMET02116 0.172 0.098 DBMET02118 0.149 0.117 DBMET02117 | DBMET02118 | |
| 0.046 | 0.006 | 0.046 | Prostaglandin E2 agonist | |||
| 0.112 | 0.073 | 0.112 | Cholesterol synthesis inhibitor | |||
| 0.071 | 0.032 | 0.072 | Prostaglandin EP2 antagonist | 0.072 0.031 DBMET02115 | DBMET02115 | |
| 0.133 | 0.095 | 0.173 | Phospholipase A2 inhibitor | 0.173 0.058 DBMET02116 0.145 0.079 DBMET02117 | DBMET02116 | |
| 0.135 | 0.098 | 0.145 | Heat shock protein 70 antagonist | 0.138 0.083 DBMET02115 0.141 0.071 DBMET02116 0.132 0.109 DBMET02118 0.145 0.058 DBMET02117 | DBMET02117 | |
| 0.055 | 0.026 | 0.06 | Bromodomain-containing protein 3 inhibitor | 0.06 0.021 DBMET02116 | DBMET02116 | |
| 0.08 | 0.052 | 0.08 | Somatostatin 1 agonist | |||
| 0.064 | 0.037 | 0.064 | Acetylcholine M3 receptor antagonist | |||
| 0.117 | 0.091 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | 0.126 0.068 DBMET02116 | DBMET02116 | |
| 0.07 | 0.046 | 0.07 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.08 | 0.058 | 0.084 | Opioid kappa receptor antagonist | 0.084 0.053 DBMET02116 | DBMET02116 | |
| 0.143 | 0.121 | 0.147 | Anesthetic general | 0.137 0.129 DBMET02116 0.147 0.117 DBMET02118 | DBMET02118 | |
| 0.062 | 0.041 | 0.062 | Beta 2 adrenoreceptor agonist | |||
| 0.184 | 0.167 | 0.266 | Tyrosine 3 hydroxylase inhibitor | 0.266 0.054 DBMET02116 | DBMET02116 | |
| 0.043 | 0.027 | 0.043 | DNA gyrase subunit A inhibitor | |||
| 0.028 | 0.013 | 0.028 | Prostaglandin EP2 agonist | |||
| 0.022 | 0.008 | 0.022 | Prostaglandin EP4 agonist | |||
| 0.141 | 0.129 | 0.314 | Non-steroidal antiinflammatory agent | 0.314 0.025 DBMET02115 0.167 0.098 DBMET02118 0.298 0.028 DBMET02117 | DBMET02115 | |
| 0.095 | 0.085 | 0.095 | Nav1.4 sodium channel blocker | |||
| 0.057 | 0.047 | 0.057 | Acetylcholine M5 receptor antagonist | |||
| 0.051 | 0.041 | 0.051 | NMDA 2B receptor antagonist | |||
| 0.028 | 0.019 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET02115 0.029 0.018 DBMET02118 | DBMET02115 | |
| 0.152 | 0.145 | 0.221 | Antiamyloidogenic | 0.221 0.086 DBMET02115 0.21 0.093 DBMET02118 | DBMET02115 | |
| 0.021 | 0.015 | 0.023 | Nociceptin (N/OFQ) receptor agonist | 0.023 0.013 DBMET02116 | DBMET02116 | |
| 0.057 | 0.05 | 0.057 | NMDA 2C receptor antagonist | |||
| 0.078 | 0.072 | 0.081 | Opioid antagonist | 0.081 0.068 DBMET02116 | DBMET02116 | |
| 0.057 | 0.052 | 0.068 | Prostaglandin F2 alpha antagonist | 0.068 0.034 DBMET02116 0.056 0.053 DBMET02117 | DBMET02116 | |
| 0.039 | 0.033 | 0.039 | Dopamine D5 antagonist | |||
| 0.12 | 0.115 | 0.234 | NOS3 expression enhancer | 0.226 0.032 DBMET02115 0.122 0.112 DBMET02116 0.232 0.031 DBMET02118 0.234 0.03 DBMET02117 | DBMET02117 | |
| 0.032 | 0.028 | 0.032 | HMG CoA reductase inhibitor | |||
| 0.077 | 0.073 | 0.077 | Antiadrenergic | |||
| 0.085 | 0.082 | 0.085 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.032 | 0.029 | 0.034 | p53 inhibitor | 0.034 0.027 DBMET02116 | DBMET02116 | |
| 0.075 | 0.073 | 0.075 | Adrenaline antagonist | |||
| 0.041 | 0.04 | 0.049 | Sigma receptor antagonist | 0.049 0.035 DBMET02116 | DBMET02116 | |
| 0.059 | 0.058 | 0.059 | Beta 3 adrenoreceptor antagonist | |||
| 0.043 | 0.042 | 0.043 | Beta adrenoreceptor agonist | |||
| 0.147 | 0.149 | 0.286 | Platelet antagonist | 0.286 0.058 DBMET02115 0.248 0.073 DBMET02118 0.263 0.067 DBMET02117 | DBMET02115 | |
| 0.091 | 0.096 | 0.113 | DOPA decarboxylase inhibitor | 0.113 0.054 DBMET02116 | DBMET02116 | |
| 0.122 | 0.129 | 0.229 | Interferon gamma antagonist | 0.19 0.045 DBMET02115 0.13 0.111 DBMET02116 0.229 0.033 DBMET02118 0.229 0.033 DBMET02117 | DBMET02117 | |
| 0.048 | 0.06 | 0.065 | Sphingosine 1-phosphate receptor 3 antagonist | 0.065 0.031 DBMET02116 | DBMET02116 | |
| 0.045 | 0.057 | 0.055 | Leukotriene B4 antagonist | 0.055 0.035 DBMET02115 | DBMET02115 | |
| 0.042 | 0.059 | 0.078 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.078 0.017 DBMET02116 | DBMET02116 | |
| 0.076 | 0.093 | 0.192 | Monophenol monooxygenase inhibitor | 0.192 0.035 DBMET02115 0.131 0.055 DBMET02118 0.189 0.036 DBMET02117 | DBMET02115 | |
| 0.01 | 0.027 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET02115 | DBMET02115 | |
| 0.076 | 0.095 | 0.086 | Creatine kinase inhibitor | 0.086 0.078 DBMET02116 | DBMET02116 | |
| 0.145 | 0.165 | 0.265 | Vasodilator | 0.264 0.062 DBMET02115 0.257 0.065 DBMET02118 0.265 0.062 DBMET02117 | DBMET02117 | |
| 0.048 | 0.071 | 0.075 | Dopamine D1 antagonist | 0.075 0.036 DBMET02116 | DBMET02116 | |
| 0.117 | 0.141 | 0.295 | Nitric oxide antagonist | 0.282 0.044 DBMET02115 0.26 0.049 DBMET02118 0.295 0.041 DBMET02117 | DBMET02117 | |
| 0.089 | 0.113 | 0.126 | Photosensitizer | 0.126 0.05 DBMET02115 0.108 0.075 DBMET02118 0.119 0.058 DBMET02117 | DBMET02115 | |
| 0.151 | 0.178 | 0.537 | Hypoglycemic | 0.507 0.015 DBMET02115 0.452 0.02 DBMET02118 0.537 0.012 DBMET02117 | DBMET02117 | |
| 0.038 | 0.07 | 0.053 | Acetyl-CoA transferase inhibitor | 0.053 0.037 DBMET02116 | DBMET02116 | |
| 0.059 | 0.101 | 0.119 | Glycine receptor antagonist | 0.1 0.032 DBMET02115 0.085 0.049 DBMET02118 0.119 0.019 DBMET02117 | DBMET02117 | |
| 0.051 | 0.102 | 0.091 | HIV-1 integrase inhibitor | 0.091 0.03 DBMET02116 | DBMET02116 | |
| 0.109 | 0.162 | 0.153 | Melanin inhibitor | 0.153 0.077 DBMET02115 0.15 0.082 DBMET02117 | DBMET02115 | |
| 0.07 | 0.126 | 0.117 | Cystathionine beta-synthase inhibitor | 0.117 0.06 DBMET02116 | DBMET02116 | |
| 0.027 | 0.092 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.085 0.017 DBMET02115 0.077 0.021 DBMET02118 0.081 0.019 DBMET02117 | DBMET02115 | |
| 0.063 | 0.128 | 0.131 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.091 0.064 DBMET02116 0.131 0.033 DBMET02117 | DBMET02117 | |
| 0.073 | 0.14 | 0.15 | Toll-Like receptor 4 antagonist | 0.14 0.027 DBMET02115 0.15 0.021 DBMET02118 0.141 0.027 DBMET02117 | DBMET02118 | |
| 0.072 | 0.142 | 0.118 | Multidrug resistance-associated protein 1 inhibitor | 0.103 0.073 DBMET02115 0.093 0.091 DBMET02116 0.118 0.05 DBMET02118 0.114 0.056 DBMET02117 | DBMET02118 | |
| 0.021 | 0.092 | 0.036 | Substance P antagonist | 0.036 0.032 DBMET02118 | DBMET02118 | |
| 0.057 | 0.13 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.072 DBMET02116 | DBMET02116 | |
| 0.032 | 0.105 | 0.092 | Factor IXa inhibitor | 0.076 0.017 DBMET02115 0.092 0.012 DBMET02118 | DBMET02118 | |
| 0.015 | 0.089 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.021 DBMET02116 | DBMET02116 | |
| 0.031 | 0.107 | 0.065 | Alpha-mannosidase inhibitor | 0.065 0.021 DBMET02115 0.05 0.043 DBMET02118 0.056 0.032 DBMET02117 | DBMET02115 | |
| 0.117 | 0.198 | 0.236 | Neurotrophic factor enhancer | 0.231 0.051 DBMET02116 0.236 0.047 DBMET02117 | DBMET02117 | |
| 0.167 | 0.25 | 0.269 | 15-Lipoxygenase inhibitor | 0.269 0.15 DBMET02116 | DBMET02116 | |
| 0.02 | 0.108 | 0.03 | Thiazolidinedione | 0.03 0.02 DBMET02116 | DBMET02116 | |
| 0.065 | 0.154 | 0.399 | Amylase inhibitor | 0.231 0.034 DBMET02115 0.152 0.063 DBMET02116 0.196 0.046 DBMET02118 0.399 0.009 DBMET02117 | DBMET02117 | |
| 0.164 | 0.256 | 0.289 | Histamine release inhibitor | 0.242 0.161 DBMET02115 0.234 0.168 DBMET02118 0.289 0.129 DBMET02117 | DBMET02117 | |
| 0.082 | 0.173 | 0.166 | Protein kinase stimulant | 0.139 0.076 DBMET02115 0.166 0.058 DBMET02117 | DBMET02117 | |
| 0.045 | 0.138 | 0.086 | Macrophage migration inhibitory factor inhibitor | 0.086 0.044 DBMET02116 | DBMET02116 | |
| 0.02 | 0.114 | 0.056 | Mannosidase inhibitor | 0.056 0.019 DBMET02115 0.044 0.034 DBMET02117 | DBMET02115 | |
| 0.065 | 0.16 | 0.208 | Beta glucuronidase inhibitor | 0.145 0.027 DBMET02115 0.093 0.082 DBMET02116 0.149 0.025 DBMET02118 0.208 0.012 DBMET02117 | DBMET02117 | |
| 0.152 | 0.248 | 0.533 | Antithrombotic | 0.533 0.025 DBMET02115 0.439 0.04 DBMET02118 0.436 0.041 DBMET02117 | DBMET02115 | |
| 0.154 | 0.25 | 0.404 | Immunosuppressant | 0.404 0.061 DBMET02115 0.386 0.069 DBMET02118 0.402 0.062 DBMET02117 | DBMET02115 | |
| 0.036 | 0.133 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.046 DBMET02115 | DBMET02115 | |
| 0.07 | 0.176 | 0.205 | Cyclooxygenase 3 inhibitor | 0.205 0.017 DBMET02115 0.149 0.049 DBMET02118 0.163 0.038 DBMET02117 | DBMET02115 | |
| 0.053 | 0.161 | 0.143 | Topoisomerase II inhibitor | 0.143 0.053 DBMET02115 0.12 0.067 DBMET02118 0.134 0.057 DBMET02117 | DBMET02115 | |
| 0.097 | 0.206 | 0.167 | Interleukin 6 antagonist | 0.167 0.068 DBMET02115 0.155 0.082 DBMET02117 | DBMET02115 | |
| 0.113 | 0.224 | 0.448 | Antioxidant | 0.392 0.036 DBMET02115 0.164 0.149 DBMET02116 0.356 0.045 DBMET02118 0.448 0.027 DBMET02117 | DBMET02117 | |
| 0.011 | 0.121 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET02115 0.025 0.016 DBMET02118 0.029 0.013 DBMET02117 | DBMET02117 | |
| 0.054 | 0.165 | 0.082 | Triose-phosphate isomerase inhibitor | 0.082 0.072 DBMET02115 0.082 0.072 DBMET02118 0.081 0.073 DBMET02117 | DBMET02118 | |
| 0.017 | 0.13 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET02115 0.028 0.014 DBMET02118 0.028 0.014 DBMET02117 | DBMET02117 | |
| 0.097 | 0.213 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.168 0.035 DBMET02116 | DBMET02116 | |
| 0.061 | 0.179 | 0.122 | Cyclooxygenase 1 inhibitor | 0.122 0.078 DBMET02116 | DBMET02116 | |
| 0.04 | 0.163 | 0.059 | Lipocortins synthesis agonist | 0.056 0.046 DBMET02115 0.055 0.05 DBMET02118 0.059 0.038 DBMET02117 | DBMET02117 | |
| 0.019 | 0.156 | 0.058 | Antibiotic Aminoglycoside-like | 0.058 0.009 DBMET02115 0.052 0.012 DBMET02118 0.058 0.009 DBMET02117 | DBMET02117 | |
| 0.053 | 0.191 | 0.113 | DNA polymerase I inhibitor | 0.113 0.074 DBMET02118 | DBMET02118 | |
| 0.01 | 0.154 | 0.05 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET02115 0.05 0.005 DBMET02117 | DBMET02117 | |
| 0.028 | 0.176 | 0.079 | Nicotinic alpha4beta2 receptor antagonist | 0.079 0.052 DBMET02116 | DBMET02116 | |
| 0.091 | 0.246 | 0.41 | Free radical scavenger | 0.35 0.039 DBMET02115 0.159 0.135 DBMET02116 0.324 0.045 DBMET02118 0.41 0.027 DBMET02117 | DBMET02117 | |
| 0.119 | 0.28 | 0.246 | DNA synthesis inhibitor | 0.222 0.092 DBMET02115 0.215 0.102 DBMET02118 0.246 0.069 DBMET02117 | DBMET02117 | |
| 0.019 | 0.181 | 0.114 | Antineoplastic antibiotic | 0.106 0.044 DBMET02115 0.114 0.04 DBMET02118 0.104 0.044 DBMET02117 | DBMET02118 | |
| 0.057 | 0.221 | 0.123 | Cyclooxygenase inhibitor | 0.123 0.095 DBMET02116 | DBMET02116 | |
| 0.104 | 0.296 | 0.355 | Transcription factor NF kappa B inhibitor | 0.352 0.076 DBMET02115 0.354 0.076 DBMET02118 0.355 0.075 DBMET02117 | DBMET02117 | |
| 0.023 | 0.216 | 0.064 | Glucose-6-phosphate translocase inhibitor | 0.059 0.024 DBMET02115 0.054 0.031 DBMET02118 0.064 0.02 DBMET02117 | DBMET02117 | |
| 0.044 | 0.245 | 0.16 | AMP-activated protein kinase stimulant | 0.144 0.032 DBMET02115 0.138 0.036 DBMET02118 0.16 0.022 DBMET02117 | DBMET02117 | |
| 0.048 | 0.253 | 0.108 | Transcription factor NF kappa B stimulant | 0.103 0.036 DBMET02115 0.1 0.039 DBMET02118 0.108 0.032 DBMET02117 | DBMET02117 | |
| 0.032 | 0.238 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.031 DBMET02118 | DBMET02118 | |
| 0.006 | 0.213 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.021 DBMET02115 0.037 0.009 DBMET02117 | DBMET02117 | |
| 0.072 | 0.282 | 0.342 | Immunostimulant | 0.342 0.067 DBMET02115 0.279 0.085 DBMET02118 0.272 0.088 DBMET02117 | DBMET02115 | |
| 0.131 | 0.348 | 0.299 | Analgesic | 0.299 0.142 DBMET02118 | DBMET02118 | |
| 0.024 | 0.257 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.025 DBMET02116 | DBMET02116 | |
| 0.05 | 0.289 | 0.477 | Angiogenesis stimulant | 0.453 0.015 DBMET02115 0.432 0.017 DBMET02118 0.477 0.013 DBMET02117 | DBMET02117 | |
| 0.081 | 0.327 | 0.171 | ATPase inhibitor | 0.171 0.07 DBMET02115 0.167 0.075 DBMET02117 | DBMET02115 | |
| 0.027 | 0.279 | 0.095 | Expectorant | 0.095 0.074 DBMET02115 | DBMET02115 | |
| 0.115 | 0.371 | 0.339 | Apoptosis antagonist | 0.306 0.081 DBMET02115 0.305 0.082 DBMET02118 0.339 0.061 DBMET02117 | DBMET02117 | |
| 0.025 | 0.284 | 0.105 | Topoisomerase I inhibitor | 0.105 0.066 DBMET02115 0.097 0.072 DBMET02118 0.104 0.067 DBMET02117 | DBMET02115 | |
| 0.037 | 0.297 | 0.169 | Acetylcholinesterase inhibitor | 0.169 0.044 DBMET02116 | DBMET02116 | |
| 0.063 | 0.326 | 0.309 | Hepatoprotectant | 0.29 0.032 DBMET02115 0.282 0.035 DBMET02118 0.309 0.027 DBMET02117 | DBMET02117 | |
| 0.091 | 0.355 | 0.192 | Gastrin inhibitor | 0.192 0.161 DBMET02116 | DBMET02116 | |
| 0.032 | 0.307 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 DBMET02117 | DBMET02117 | |
| 0.028 | 0.312 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.095 0.048 DBMET02115 0.09 0.057 DBMET02117 | DBMET02115 | |
| 0.079 | 0.366 | 0.26 | Superoxide dismutase inhibitor | 0.26 0.068 DBMET02116 | DBMET02116 | |
| 0.019 | 0.313 | 0.073 | Heparanase inhibitor | 0.067 0.014 DBMET02115 0.06 0.022 DBMET02118 0.073 0.01 DBMET02117 | DBMET02117 | |
| 0.032 | 0.344 | 0.206 | Thrombolytic | 0.198 0.053 DBMET02115 0.172 0.066 DBMET02118 0.206 0.049 DBMET02117 | DBMET02117 | |
| 0.011 | 0.331 | 0.262 | Selectin antagonist | 0.26 0.008 DBMET02115 0.214 0.01 DBMET02118 0.262 0.008 DBMET02117 | DBMET02117 | |
| 0.038 | 0.37 | 0.164 | Cholinergic | 0.164 0.066 DBMET02116 | DBMET02116 | |
| 0.031 | 0.375 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 DBMET02117 | DBMET02117 | |
| 0.03 | 0.383 | 0.167 | Lipid peroxidase inhibitor | 0.13 0.084 DBMET02115 0.121 0.093 DBMET02118 0.167 0.057 DBMET02117 | DBMET02117 | |
| 0.12 | 0.478 | 0.61 | Antiinflammatory | 0.577 0.06 DBMET02115 0.603 0.053 DBMET02118 0.61 0.051 DBMET02117 | DBMET02117 | |
| 0.049 | 0.413 | 0.152 | Insulin secretagoues | 0.152 0.072 DBMET02115 0.132 0.094 DBMET02118 0.146 0.078 DBMET02117 | DBMET02115 | |
| 0.044 | 0.415 | 0.279 | Platelet adhesion inhibitor | 0.255 0.048 DBMET02115 0.237 0.054 DBMET02118 0.279 0.04 DBMET02117 | DBMET02117 | |
| 0.1 | 0.474 | 0.441 | Apoptosis agonist | 0.368 0.13 DBMET02115 0.417 0.106 DBMET02118 0.441 0.095 DBMET02117 | DBMET02117 | |
| 0.037 | 0.48 | 0.189 | Hemostatic | 0.17 0.049 DBMET02115 0.132 0.093 DBMET02118 0.189 0.038 DBMET02117 | DBMET02117 | |
| 0.08 | 0.541 | 0.123 | CC chemokine 6 receptor antagonist | 0.121 0.11 DBMET02115 0.122 0.105 DBMET02118 0.123 0.1 DBMET02117 | DBMET02117 | |
| 0.024 | 0.491 | 0.149 | Anticoagulant | 0.138 0.092 DBMET02115 0.126 0.104 DBMET02118 0.149 0.081 DBMET02117 | DBMET02117 | |
| 0.033 | 0.526 | 0.287 | Tumour necrosis factor alpha release inhibitor | 0.235 0.082 DBMET02115 0.169 0.135 DBMET02118 0.287 0.058 DBMET02117 | DBMET02117 | |
| 0.015 | 0.511 | 0.074 | Cell adhesion molecule inhibitor | 0.074 0.062 DBMET02117 | DBMET02117 | |
| 0.026 | 0.522 | 0.136 | Cell adhesion inhibitor | 0.124 0.062 DBMET02115 0.097 0.095 DBMET02118 0.136 0.055 DBMET02117 | DBMET02117 | |
| 0.04 | 0.554 | 0.145 | DNA repair enzyme inhibitor | 0.145 0.036 DBMET02117 | DBMET02117 | |
| 0.057 | 0.615 | 0.226 | Caspase 3 stimulant | 0.226 0.136 DBMET02118 | DBMET02118 | |
| 0.017 | 0.612 | 0.213 | Alpha-glucosidase inhibitor | 0.213 0.211 DBMET02117 | DBMET02117 | |
| 0.032 | 0.701 | 0.241 | Immunomodulator | 0.207 0.156 DBMET02115 0.241 0.122 DBMET02118 0.21 0.152 DBMET02117 | DBMET02118 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |